Genetic analyses identify brain functional networks associated with the risk of Parkinson's disease and drug-induced parkinsonism

被引:0
|
作者
Chen, Lin [1 ,2 ]
Fang, Ming-juan [2 ]
Yu, Xu-en [1 ,2 ]
Xu, Yin [1 ,2 ]
机构
[1] Anhui Univ Chinese Med, Inst Neurol, 357 Changjiang Middle Rd, Hefei 230061, Peoples R China
[2] Anhui Univ Chinese Med, 350 Longzihu Rd, Hefei 230012, Peoples R China
关键词
brain functional networks; causal relationship; Mendelian randomization; parkinsonism; rsfMRI phenotypes; INDEPENDENT COMPONENT ANALYSIS; MENDELIAN RANDOMIZATION; MOTOR NETWORK; CONNECTIVITY; INSTRUMENTS; REORGANIZATION; ACTIVATION; MORTALITY; DYNAMICS; BIAS;
D O I
10.1093/cercor/bhae506
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Brain functional networks are associated with parkinsonism in observational studies. However, the causal effects between brain functional networks and parkinsonism remain unclear. We aimed to assess the potential bidirectional causal associations between 191 brain resting-state functional magnetic resonance imaging (rsfMRI) phenotypes and parkinsonism including Parkinson's disease (PD) and drug-induced parkinsonism (DIP). We used Mendelian randomization (MR) to assess the bidirectional associations between brain rsfMRI phenotypes and parkinsonism, followed by several sensitivity analyses for robustness validation. In the forward MR analyses, we found that three rsfMRI phenotypes genetically determined the risk of parkinsonism. The connectivity in the visual network decreased the risk of PD (OR = 0.391, 95% CI = 0.235 similar to 0.649, P = 2.83 x 10(-4), P_FDR = 0.039). The connectivity of salience and motor networks increased the risk of DIP (OR = 4.102, 95% CI = 1.903 similar to 8.845, P = 3.17 x 10(-4), P_FDR = 0.044). The connectivity of limbic and default mode networks increased the risk of DIP (OR = 14.526, 95% CI = 3.130 similar to 67.408, P = 6.32 x 10(-4), P_FDR = 0.0437). The reverse MR analysis indicated that PD and DIP had no effect on brain rsfMRI phenotypes. Our findings reveal causal relationships between brain functional networks and parkinsonism, providing important interventional and therapeutic targets for different parkinsonism.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Differentiating drug-induced parkinsonism from Parkinson's disease: An update on non-motor symptoms and investigations
    Brigo, Francesco
    Erro, Roberto
    Marangi, Antonio
    Bhatia, Kailash
    Tinazzi, Michele
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (08) : 808 - 814
  • [42] Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease
    Blauwendraat, Cornelis
    Tayebi, Nahid
    Woo, Elizabeth Geena
    Lopez, Grisel
    Fierro, Luca
    Toffoli, Marco
    Limbachiya, Naomi
    Hughes, Derralynn
    Pitz, Vanessa
    Patel, Dhairya
    Vitale, Dan
    Koretsky, Mathew J.
    Hernandez, Dena
    Real, Raquel
    Alcalay, Roy N.
    Nalls, Mike A.
    Morris, Huw R.
    Schapira, Anthony H. V.
    Balwani, Manisha
    Sidransky, Ellen
    MOVEMENT DISORDERS, 2023, 38 (05) : 899 - 903
  • [43] Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
    Fernandez, HH
    Friedman, JH
    Jacques, C
    Rosenfeld, M
    MOVEMENT DISORDERS, 1999, 14 (03) : 484 - 487
  • [44] Drug-induced impulse control disorders in Parkinson’s disease
    J. Reiff
    W. H. Jost
    Journal of Neurology, 2011, 258 : 323 - 327
  • [45] Pathophysiological basis of drug-induced dyskinesias in Parkinson's disease
    Deogaonkar, M
    Subramanian, T
    BRAIN RESEARCH REVIEWS, 2005, 50 (01) : 156 - 168
  • [46] Involvement of exosomes in drug-induced model of Parkinson's disease
    Tsutsumi, Reiho
    Seki, Takahiro
    Oshima, Mutsumi
    Kurauchi, Yuki
    Hisatsune, Akinori
    Katsuki, Hiroshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S232 - S232
  • [47] Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease
    Duggal, Harpreet S.
    Singh, Ira
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (02): : 583 - 584
  • [48] Drug-induced psychosis in Parkinson's disease - A review of management
    Mendis, T
    Barclay, CL
    Mohr, E
    CNS DRUGS, 1996, 5 (03) : 166 - 174
  • [49] GPi pallidotomy for Parkinson's disease with drug-induced psychosis
    Yamada, K
    Goto, S
    Ushio, Y
    PARKINSONISM & RELATED DISORDERS, 2003, 10 (01) : 35 - 40
  • [50] Drug-induced impulse control disorders in Parkinson's disease
    Reiff, J.
    Jost, W. H.
    JOURNAL OF NEUROLOGY, 2011, 258 : S323 - S327